Partially-sighted person
Client access
Version française English Version
CDL Pharma
offers a comprehensive system for centralized biology in clinical research

LUXEMBOURG, July 04, 2018, Advanced Biological Laboratories (ABL - announced today that it has signed a definitive agreement to acquire CDL Pharma.



Version 1.0 – 10 July 2023

1. Ownership

CDL Pharma (hereinafter, "the owner"), a société par actions simplifiées (simplified joint stock company) registered with the Registrar of the Commercial Court of Marseille under number 481 806 602, having its registered office at 34 rue Peyssonnel, 13003 Marseille, France, subject to value-added tax, trading under number FR23481806602 and reachable at +33 4 96 20 96 20. The director and person responsible for the publication of this website is Dr. Chalom Sayada, in his capacity as Representative of Advanced Biological Laboratories (ABL) S.A., owner of CDL Pharma.

2. Site Host

The service provider that will provide direct and permanent storage of the website is the company OVH.

3. Technical Information

The user hereby acknowledges that they take cognizance of this legal notice and undertake to comply with it. The user hereby acknowledges that they have the skills and the means necessary to access and use this site. The user of the website hereby acknowledges that they have verified that the technical material it will use to connect to the site is virus-free and in perfect operating condition. This site is accessible 24 hours/day and 7 days/week, except in cases of force majeure, computer troubles, difficulties relating to the communications network structure or any other technical issues. Furthermore, for maintenance purposes, the Owner of the website may interrupt access to the site and will attempt to so inform the users prior to such interruption.

4. Site content

The information provided by CDL Pharma is for informational purposes only. CDL Pharma does not guarantee that the information provided on its site is accurate, complete or up-to-date. Consequently, the user hereby acknowledges that they use this information subject to assuming sole liability. The content of the site, its general structure and all texts, animated and still images, know-how, and all other elements constituting the site, are the exclusive property of CDL Pharma. Any partial or total representation of this site, by any procedure whatsoever, without the express consent of CDL Pharma, is prohibited and constitutes fraud as punishable under the Intellectual Property Code.

5. Hypertext link

CDL Pharma may reference, for informational purposes only, through hypertext links, other resources existing on the Internet. CDL Pharma undertakes, in the event of dispute and upon request only, to delete such hypertext link as promptly as possible. CDL Pharma may not be held liable for hypertext links added in the context of this site to other resources on the Internet network. Likewise, CDL Pharma may not be held liable for the access by users through hypertext links added in the context of the website to other resources on the Internet. Users and visitors of the website are free to link this site through a hypertext link and to put the link on their home page, subject to compliance with the spirit of the site. In any case, users who add such links to this site undertake to remove their link upon CDL Pharma’ simple request.

6. Authorization to reproduce the content

For any further information or requests to reproduce the content appearing on the CDL Pharma site (texts, graphics and illustrations), regardless of the media, the user may send such request by regular mail to the following address: CDL Pharma, 34 rue Peyssonnel, 13003 Marseille, France.